From A to B - treatment of multiple sclerosis with the interferons

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1243, 2000-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis: A Non-Experimental, Retrospective, Cohort Study

By Steinberg Stephanie C.

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 89-100

Adis International

Access to resources Recommend Favorite

Interferons in Relapsing-Remitting Multiple Sclerosis: Are There Benefits from Long-Term Use?

By Oscar Fernández

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1057-1070

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum Wang Shan Gottesman Malcolm

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β_1b in the treatment of multiple sclerosis

By Río Jordi Montalban Xavier

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite

NF-#954;B, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 6, 2008-12 ,pp. : 536-557

Bentham Science Publishers

Access to resources Recommend Favorite